Current Essential Testing in Early Breast Cancer

Download All
Learn from a multidiscipinary panel of experts and enhance your knowledge on essential testing in early breast cancer with expert commentaries, a podcast, an online module, downloadable slides, and an on-demand webcast from a live webinar with a focus on BRCA testing and the role of PARP inhibition in early-stage breast cancer.
Charles E. Geyer, Jr., MD

ClinicalThought

BRCA testing is now essential to identify patients with early breast cancer who may benefit from adjuvant olaparib.

Charles E. Geyer, Jr., MD Released: November 17, 2022

Downloadable Infographic

Review and share this quick guide with key insights on how to identify patients with breast cancer who may benefit from treatment with adjuvant olaparib.

Released: November 14, 2022
Provided by Clinical Care Options, LLC in partnership with ProCE, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by educational grants from
AstraZeneca
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings